1st Quarter - Termination
THE CONAFAY GROUP, LLC for XERIS PHARMACEUTICALS, INC.
Client
Income
$10,000
Expenses
—
Terminated
Jan 31, 2020
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Biomedical research issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE P. PAWELCZYK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.